word,tfidf
treatment,0.20381319029534628
inclusion,0.1874144278577897
criteria,0.16521996353983145
active,0.15695958333089885
contraception,0.15561128614613007
history,0.1384437793747312
infection,0.13821814054511988
disease,0.13353277984867515
informed,0.13283890280767202
consent,0.12588187698272874
methods,0.1231258933443236
positive,0.11193326843063375
therapy,0.11010597636645145
carcinoma,0.10981498595574808
women,0.1064872591086042
pregnancy,0.1062711222461376
days,0.10073525497356195
hiv,0.09868032779998492
hepatitis,0.09868032779998492
abstinence,0.0967632424434701
following,0.09604989427711721
cell,0.09604989427711721
childbearing,0.09488493057690858
age,0.09425959446790211
use,0.09178886863323969
participation,0.08729413613075589
contraceptive,0.08729413613075589
donor,0.08667917288422772
weeks,0.08667917288422772
sexual,0.08356825483754235
pregnant,0.08349873890767955
tb,0.08349873890767955
uln,0.08319317117859704
18,0.07867617311420545
female,0.07590794446152686
failure,0.07496577114311587
potential,0.07496577114311587
effective,0.07364030817804852
uncontrolled,0.07364030817804852
included,0.07343109490659175
min,0.07320999063716538
severe,0.0726230907948935
visit,0.0708085558027849
heart,0.0708085558027849
pulmonary,0.07069469585092658
creatinine,0.07069469585092658
intrauterine,0.07037326723161462
willing,0.07037326723161462
insurance,0.07037326723161462
written,0.0698822637900215
vaccine,0.06831715001537417
subject,0.06818601669897806
known,0.06774908352380464
oral,0.06774908352380464
systemic,0.06559504975022638
basal,0.06452175279229783
situ,0.06452175279229783
past,0.06452175279229783
hypersensitivity,0.06452175279229783
50,0.06325236940200402
bone,0.06185785886956076
live,0.061576608827662783
child,0.061576608827662783
10,0.06090968905378165
agent,0.06072635556922149
having,0.060318399387557516
received,0.060318399387557516
hormonal,0.05989908324858986
negative,0.05891224654243882
requiring,0.05769586028375066
marrow,0.05769586028375066
coverage,0.057178279625686876
ecog,0.05693095834614515
eligible,0.056571356401445984
30,0.0562243283573369
test,0.0562243283573369
renal,0.05596663421531688
skin,0.05507332117994381
old,0.0532436295543021
signed,0.0532436295543021
mmhg,0.0531355611230688
tuberculosis,0.0531355611230688
cervix,0.0531355611230688
curatorship,0.05277995042371096
mm3,0.05277995042371096
uveitis,0.05245078207613697
cardiac,0.05153896766089216
bilirubin,0.04991590270715822
partner,0.04934016389999246
malignancy,0.04934016389999246
nyha,0.04838162122173505
progestogen,0.04838162122173505
aged,0.047129797233951054
clearance,0.047129797233951054
adequate,0.047129797233951054
investigational,0.047129797233951054
involvement,0.046853606964447424
medical,0.046853606964447424
diagnosis,0.04658817586001434
unable,0.045544766676916114
highly,0.045544766676916114
insufficiency,0.045544766676916114
receiving,0.044583164764716424
mg,0.04451092661622505
vaccines,0.04398329201975914
hcv,0.04398329201975914
cns,0.04326044901287046
duration,0.042168246268002675
organ,0.04196062566090957
alat,0.04174936945383977
ml,0.04123857257970717
clinically,0.04123857257970717
legal,0.03993272216572658
male,0.03993272216572658
health,0.03982556591978031
chronic,0.03982556591978031
evidence,0.03982556591978031
103,0.039584962817783224
iud,0.039584962817783224
ius,0.039584962817783224
security,0.039584962817783224
month,0.039338086557102726
previous,0.039338086557102726
asat,0.03795397223076343
breastfeeding,0.03795397223076343
treated,0.03748288557155793
infectious,0.036715547453295874
cancer,0.036715547453295874
serum,0.036715547453295874
function,0.036715547453295874
psychiatric,0.03660499531858269
dl,0.03660499531858269
investigator,0.03534734792546329
respiratory,0.03534734792546329
pressure,0.03534734792546329
transdermal,0.03518663361580731
injectable,0.03518663361580731
sterilization,0.03518663361580731
hbsag,0.03518663361580731
bearing,0.03518663361580731
anti,0.035140205223335566
total,0.035140205223335566
acute,0.035140205223335566
device,0.034158575007687084
squamous,0.034158575007687084
significant,0.03409300834948903
usual,0.03409300834948903
confirmed,0.03409300834948903
ventricular,0.03327726847143881
breast,0.03327726847143881
transplantation,0.03279752487511319
treatments,0.03279752487511319
considered,0.03279752487511319
risk,0.03279752487511319
transplant,0.03279752487511319
12,0.03279752487511319
presence,0.031470469245682184
cyclophosphamide,0.031470469245682184
performance,0.031470469245682184
able,0.031470469245682184
absence,0.031470469245682184
30ml,0.030788304413831392
seropositivity,0.030788304413831392
reproductive,0.030788304413831392
permitted,0.030788304413831392
available,0.030454844526890824
associated,0.030454844526890824
grade,0.030454844526890824
specific,0.030454844526890824
hcg,0.030363177784610746
ovulation,0.030363177784610746
excipients,0.030363177784610746
indication,0.030363177784610746
ray,0.030363177784610746
checked,0.030363177784610746
virus,0.02994954162429493
social,0.02994954162429493
interventional,0.02994954162429493
medicinal,0.02994954162429493
planned,0.02994954162429493
chest,0.02994954162429493
immunosuppressive,0.02945612327121941
hypertension,0.02945612327121941
combined,0.02945612327121941
procedures,0.02945612327121941
detected,0.02945612327121941
meet,0.02945612327121941
baseline,0.02884793014187533
normal,0.02884793014187533
antibody,0.02884793014187533
selection,0.02884793014187533
matched,0.02884793014187533
period,0.02811216417866845
syndrome,0.02811216417866845
current,0.02811216417866845
fraction,0.02662181477715105
fever,0.02662181477715105
150,0.02662181477715105
men,0.02662181477715105
agents,0.02662181477715105
ejection,0.02662181477715105
rna,0.0265677805615344
feeding,0.0265677805615344
substance,0.0265677805615344
lifestyle,0.0265677805615344
abnormalities,0.0265677805615344
condom,0.0265677805615344
affiliated,0.0265677805615344
preferred,0.0265677805615344
urinary,0.0265677805615344
htlv,0.0265677805615344
provide,0.026510510944097464
french,0.026510510944097464
currently,0.026510510944097464
method,0.026510510944097464
cutaneous,0.026510510944097464
contra,0.02638997521185548
untreated,0.02638997521185548
tubal,0.02638997521185548
abuse,0.02638997521185548
unwilling,0.02638997521185548
intravaginal,0.02638997521185548
obstruction,0.02638997521185548
recurrent,0.02638997521185548
interfere,0.02638997521185548
releasing,0.02638997521185548
intercourse,0.02638997521185548
methotrexate,0.02638997521185548
barrier,0.02638997521185548
ks,0.026225391038068487
eligibility,0.026225391038068487
major,0.026225391038068487
laboratory,0.026225391038068487
hla,0.026225391038068487
stem,0.026225391038068487
status,0.026225391038068487
iv,0.02576948383044608
70,0.02576948383044608
previously,0.02576948383044608
mean,0.023602851934261638
covid,0.023602851934261638
iii,0.023602851934261638
antibodies,0.023602851934261638
symptoms,0.023602851934261638
prednisone,0.023602851934261638
international,0.023602851934261638
disorders,0.023564898616975527
receive,0.023564898616975527
left,0.023564898616975527
pcr,0.023564898616975527
protection,0.023564898616975527
chemotherapy,0.023564898616975527
participants,0.023564898616975527
screening,0.023564898616975527
20,0.023426803482223712
19,0.023426803482223712
count,0.023426803482223712
60,0.023426803482223712
eye,0.023426803482223712
40,0.023426803482223712
posterior,0.023426803482223712
diagnosed,0.02329408793000717
109,0.02329408793000717
disorder,0.02329408793000717
participate,0.02329408793000717
hemoglobin,0.02329408793000717
illness,0.02329408793000717
administered,0.02329408793000717
exclusion,0.02329408793000717
equivalent,0.02329408793000717
permanent,0.022772383338458057
immunodeficiency,0.022772383338458057
allowed,0.022772383338458057
cdai,0.022772383338458057
rituximab,0.022772383338458057
serology,0.022772383338458057
azathioprine,0.02199164600987957
sgot,0.02199164600987957
visceral,0.02199164600987957
guardianship,0.02199164600987957
upper,0.02199164600987957
symptomatic,0.02199164600987957
ag,0.02199164600987957
agree,0.02199164600987957
understanding,0.02199164600987957
fulfilling,0.02199164600987957
2n,0.02199164600987957
tutorship,0.02199164600987957
condoms,0.02199164600987957
debilitating,0.02199164600987957
artery,0.02199164600987957
sgpt,0.02199164600987957
recovered,0.02199164600987957
signs,0.021084123134001338
high,0.021084123134001338
follow,0.021084123134001338
administration,0.021084123134001338
type,0.020980312830454786
anemia,0.020980312830454786
transfusion,0.020980312830454786
obtained,0.020980312830454786
documented,0.020619286289853586
values,0.020619286289853586
meeting,0.020619286289853586
acs,0.020619286289853586
donors,0.020619286289853586
product,0.020619286289853586
lesion,0.01996636108286329
echocardiography,0.01996636108286329
arterial,0.01996636108286329
leukemia,0.01996636108286329
birth,0.01996636108286329
products,0.01996636108286329
inhibition,0.01996636108286329
intensive,0.01996636108286329
attenuated,0.01996636108286329
medication,0.01996636108286329
general,0.01996636108286329
drugs,0.01996636108286329
prevent,0.01996636108286329
contraindication,0.01996636108286329
inform,0.01996636108286329
orally,0.01996636108286329
definition,0.01996636108286329
relation,0.018976986115381716
sodium,0.018976986115381716
anaphylactic,0.018976986115381716
willingness,0.018976986115381716
1500,0.018976986115381716
harvest,0.018976986115381716
hbs,0.018976986115381716
myocardial,0.018976986115381716
mm,0.018976986115381716
smpc,0.018976986115381716
biologic,0.018976986115381716
reactions,0.018976986115381716
prophylactic,0.018976986115381716
filtration,0.018976986115381716
preinclusion,0.018976986115381716
periods,0.018976986115381716
rest,0.018976986115381716
steroid,0.018741442785778967
year,0.018741442785778967
lesions,0.018741442785778967
hospitalization,0.018357773726647937
antibiotics,0.018357773726647937
adult,0.018357773726647937
allogeneic,0.018357773726647937
right,0.018357773726647937
belimumab,0.018357773726647937
liver,0.018357773726647937
pan,0.017673673962731645
note,0.017673673962731645
initiation,0.017673673962731645
recent,0.017673673962731645
individuals,0.017673673962731645
yellow,0.017593316807903655
gfr,0.017593316807903655
hbv,0.017593316807903655
vasectomised,0.017593316807903655
guidance,0.017593316807903655
evolving,0.017593316807903655
correctly,0.017593316807903655
lateral,0.017593316807903655
lymphoblastic,0.017593316807903655
mfi,0.017593316807903655
lives,0.017593316807903655
cystitis,0.017593316807903655
infarction,0.017593316807903655
congestive,0.017593316807903655
consolidation,0.017593316807903655
implantable,0.017593316807903655
parents,0.017593316807903655
affiliation,0.017593316807903655
inadequate,0.017593316807903655
consistently,0.017593316807903655
50ml,0.017593316807903655
children,0.017593316807903655
postero,0.017593316807903655
hormone,0.017593316807903655
hg,0.017593316807903655
vasectomy,0.017593316807903655
heterosexual,0.017593316807903655
hemorrhagic,0.017593316807903655
interferon,0.016638634235719405
comply,0.016638634235719405
condition,0.016638634235719405
unless,0.016638634235719405
radiotherapy,0.016638634235719405
cervical,0.016638634235719405
intravenous,0.016638634235719405
bilateral,0.016638634235719405
monoclonal,0.016638634235719405
35,0.016638634235719405
28,0.016638634235719405
glomerular,0.016638634235719405
hepatic,0.016638634235719405
idiopathic,0.016638634235719405
rate,0.016398762437556596
randomization,0.016398762437556596
response,0.016398762437556596
sars,0.016398762437556596
adverse,0.016398762437556596
anterior,0.016398762437556596
measures,0.016398762437556596
complete,0.016398762437556596
group,0.016398762437556596
antibiotic,0.015735234622841092
sun,0.015735234622841092
central,0.015735234622841092
surgery,0.015735234622841092
platelet,0.015735234622841092
100,0.015735234622841092
corticosteroids,0.015735234622841092
tumor,0.015735234622841092
adalimumab,0.015735234622841092
care,0.015735234622841092
identical,0.015735234622841092
sle,0.015735234622841092
classification,0.015735234622841092
myelofibrosis,0.015181588892305373
antiviral,0.015181588892305373
ctfg,0.015181588892305373
demyelinating,0.015181588892305373
stable,0.015181588892305373
nursing,0.015181588892305373
allergic,0.015181588892305373
quantiferon,0.015181588892305373
occlusion,0.015181588892305373
intestinal,0.015181588892305373
applicable,0.015181588892305373
suspected,0.015181588892305373
progressive,0.015181588892305373
92,0.015181588892305373
isolated,0.015181588892305373
73m2,0.015181588892305373
75,0.015181588892305373
suggestive,0.015181588892305373
concurrent,0.015181588892305373
woman,0.015181588892305373
philadelphia,0.015181588892305373
york,0.015181588892305373
mn,0.015181588892305373
tract,0.015181588892305373
dlco,0.015181588892305373
corrected,0.014728061635609704
laherparepvec,0.014728061635609704
injections,0.014728061635609704
replacement,0.014728061635609704
human,0.014728061635609704
stopping,0.014728061635609704
talimogene,0.014728061635609704
needs,0.014728061635609704
mofetil,0.014728061635609704
lung,0.014728061635609704
section,0.014728061635609704
autoimmune,0.014728061635609704
nervous,0.014728061635609704
mycophenolate,0.014728061635609704
management,0.014056082089334225
vasculitis,0.014056082089334225
hsct,0.014056082089334225
life,0.014056082089334225
steroids,0.014056082089334225
kg,0.014056082089334225
urine,0.013310907388575524
half,0.013310907388575524
metastatic,0.013310907388575524
ast,0.013310907388575524
neutropenia,0.013310907388575524
does,0.013310907388575524
times,0.013310907388575524
scd,0.013310907388575524
prescribed,0.013310907388575524
diabetes,0.013310907388575524
nb,0.013310907388575524
ct,0.013310907388575524
authorized,0.013310907388575524
immunosuppressant,0.013310907388575524
colon,0.013310907388575524
alt,0.013310907388575524
sclerosis,0.013310907388575524
atrial,0.013310907388575524
excluded,0.013310907388575524
conceive,0.01319498760592774
estrogen,0.01319498760592774
man,0.01319498760592774
mol,0.01319498760592774
azoospermia,0.01319498760592774
resting,0.01319498760592774
sexually,0.01319498760592774
intravitreal,0.01319498760592774
ipss,0.01319498760592774
proteins,0.01319498760592774
histologically,0.01319498760592774
unwillingness,0.01319498760592774
universal,0.01319498760592774
cmu,0.01319498760592774
insulin,0.01319498760592774
vitiligo,0.01319498760592774
systolic,0.01319498760592774
catheterization,0.01319498760592774
psoriasis,0.01319498760592774
5xuln,0.01319498760592774
foam,0.01319498760592774
progressing,0.01319498760592774
consisting,0.01319498760592774
starch,0.01319498760592774
psychological,0.01319498760592774
vaccination,0.01319498760592774
preclude,0.01319498760592774
potassium,0.01319498760592774
pneumonia,0.01319498760592774
her2,0.01319498760592774
vaginal,0.01319498760592774
mellitus,0.01319498760592774
salt,0.01319498760592774
alcohol,0.01319498760592774
lymphopenia,0.01319498760592774
exceptions,0.01319498760592774
advance,0.01319498760592774
macrophages,0.01319498760592774
hypothyroidism,0.01319498760592774
ring,0.01319498760592774
hemopathy,0.01319498760592774
finished,0.01319498760592774
abscess,0.01319498760592774
refraining,0.01319498760592774
coronary,0.01319498760592774
solid,0.01319498760592774
nilotinib,0.01319498760592774
contraindications,0.01319498760592774
contraceptives,0.01319498760592774
explorations,0.01319498760592774
lipase,0.01319498760592774
threatening,0.013112695519034243
aiec,0.013112695519034243
completed,0.013112695519034243
80,0.013112695519034243
visits,0.013112695519034243
evaluated,0.013112695519034243
scale,0.013112695519034243
icu,0.013112695519034243
need,0.013112695519034243
red,0.013112695519034243
cov2,0.013112695519034243
required,0.013112695519034243
specified,0.013112695519034243
bd,0.013112695519034243
graall,0.011782449308487764
voc,0.011782449308487764
prophylaxis,0.011782449308487764
treosulfan,0.011782449308487764
hours,0.011782449308487764
enrolled,0.011782449308487764
initial,0.011782449308487764
intermediate,0.011782449308487764
causes,0.011782449308487764
reasons,0.011782449308487764
association,0.011782449308487764
sibling,0.011782449308487764
respectively,0.011782449308487764
infliximab,0.011782449308487764
recipient,0.011782449308487764
nomenclature,0.011782449308487764
cd,0.011782449308487764
national,0.011782449308487764
standardization,0.011782449308487764
biological,0.011782449308487764
malignant,0.011782449308487764
imaging,0.011782449308487764
discontinuation,0.011782449308487764
formula,0.011782449308487764
secondary,0.011713401741111856
procedure,0.011713401741111856
assessment,0.011713401741111856
ii,0.011713401741111856
corticosteroid,0.011713401741111856
cells,0.011713401741111856
injection,0.011713401741111856
neoplasm,0.011386191669229028
haplotype,0.011386191669229028
topical,0.011386191669229028
mentioned,0.011386191669229028
dependence,0.011386191669229028
excluding,0.011386191669229028
diaphragm,0.011386191669229028
neuropathy,0.011386191669229028
pneumonitis,0.011386191669229028
compatible,0.011386191669229028
ileum,0.011386191669229028
masquerade,0.011386191669229028
takes,0.011386191669229028
bolus,0.011386191669229028
older,0.011386191669229028
regulations,0.011386191669229028
karyotype,0.011386191669229028
latent,0.011386191669229028
entire,0.011386191669229028
entering,0.011386191669229028
understand,0.011386191669229028
containing,0.011386191669229028
congenital,0.011386191669229028
consistent,0.011386191669229028
anc,0.011386191669229028
emergency,0.011386191669229028
achieve,0.011386191669229028
findings,0.011386191669229028
hydroxyurea,0.011386191669229028
transaminases,0.011386191669229028
reliability,0.011386191669229028
diameter,0.011386191669229028
influenza,0.011386191669229028
requires,0.011386191669229028
spot,0.011386191669229028
applies,0.011386191669229028
father,0.011386191669229028
igra,0.011386191669229028
long,0.010490156415227393
ileal,0.010490156415227393
vascular,0.010490156415227393
frequency,0.010490156415227393
25,0.010490156415227393
ensure,0.010490156415227393
randomized,0.010490156415227393
week,0.010490156415227393
viral,0.010490156415227393
ssc,0.010490156415227393
body,0.010490156415227393
stage,0.010490156415227393
recommended,0.010490156415227393
thrombosis,0.010490156415227393
course,0.010490156415227393
therapies,0.010490156415227393
documentation,0.009983180541431646
range,0.009983180541431646
pd,0.009983180541431646
abnormal,0.009983180541431646
scan,0.009983180541431646
haploidentical,0.009983180541431646
120,0.009983180541431646
preexisting,0.009983180541431646
segment,0.009983180541431646
minor,0.009983180541431646
cohort,0.009983180541431646
45,0.009983180541431646
minimum,0.009983180541431646
base,0.009983180541431646
tissue,0.009983180541431646
immunotherapy,0.009983180541431646
inactive,0.009983180541431646
newly,0.009983180541431646
assay,0.009983180541431646
doppler,0.009983180541431646
gold,0.009983180541431646
physician,0.009983180541431646
antigen,0.009983180541431646
oxygen,0.009983180541431646
capacity,0.009983180541431646
stenosis,0.009983180541431646
efficient,0.009983180541431646
state,0.009983180541431646
accordance,0.009983180541431646
acceptable,0.009983180541431646
acquired,0.009983180541431646
cyclosporine,0.009983180541431646
reaction,0.009983180541431646
severity,0.009370721392889483
post,0.009370721392889483
validated,0.009370721392889483
multiple,0.009370721392889483
cryoglobulinemia,0.009370721392889483
assessed,0.009370721392889483
activity,0.009370721392889483
retinal,0.009370721392889483
levels,0.009370721392889483
optimal,0.009370721392889483
events,0.009370721392889483
relapse,0.009370721392889483
recommendations,0.009370721392889483
peripheral,0.009370721392889483
end,0.009370721392889483
placebo,0.009370721392889483
progression,0.009370721392889483
primary,0.009370721392889483
hematopoietic,0.009370721392889483
2008,0.008836836981365823
weight,0.008836836981365823
wbc,0.008836836981365823
gamma,0.008836836981365823
surface,0.008836836981365823
aml,0.008836836981365823
table,0.008836836981365823
aplastic,0.008836836981365823
examination,0.008836836981365823
taking,0.008836836981365823
endemic,0.008836836981365823
involving,0.008836836981365823
discontinued,0.008836836981365823
measured,0.008836836981365823
determined,0.008836836981365823
repeated,0.008836836981365823
biopsy,0.008836836981365823
moderate,0.008836836981365823
mri,0.008836836981365823
extra,0.008836836981365823
context,0.008836836981365823
22,0.008836836981365823
regimen,0.008836836981365823
suicidal,0.008796658403951827
adrenal,0.008796658403951827
allergy,0.008796658403951827
instructions,0.008796658403951827
substrate,0.008796658403951827
ischemic,0.008796658403951827
jelly,0.008796658403951827
altered,0.008796658403951827
amenable,0.008796658403951827
amylase,0.008796658403951827
suicide,0.008796658403951827
interstitial,0.008796658403951827
intermittent,0.008796658403951827
alkylating,0.008796658403951827
anhydrous,0.008796658403951827
lactation,0.008796658403951827
aid,0.008796658403951827
ll,0.008796658403951827
largest,0.008796658403951827
irradiated,0.008796658403951827
epilepsy,0.008796658403951827
septic,0.008796658403951827
ligation,0.008796658403951827
dsa,0.008796658403951827
silica,0.008796658403951827
auxiliary,0.008796658403951827
bacillus,0.008796658403951827
measurable,0.008796658403951827
arrhythmia,0.008796658403951827
hb,0.008796658403951827
geno,0.008796658403951827
hbcab,0.008796658403951827
1st,0.008796658403951827
3n,0.008796658403951827
cluster,0.008796658403951827
vedolizumab,0.008796658403951827
predicted,0.008796658403951827
dioxide,0.008796658403951827
sale,0.008796658403951827
titanium,0.008796658403951827
excised,0.008796658403951827
explained,0.008796658403951827
expecting,0.008796658403951827
implants,0.008796658403951827
disodium,0.008796658403951827
iga,0.008796658403951827
thrombopenia,0.008796658403951827
monocular,0.008796658403951827
morphologic,0.008796658403951827
modifying,0.008796658403951827
thyroxine,0.008796658403951827
belonging,0.008796658403951827
scanner,0.008796658403951827
blast,0.008796658403951827
rf,0.008796658403951827
rhythm,0.008796658403951827
necessitating,0.008796658403951827
myelodysplasia,0.008796658403951827
cytolysis,0.008796658403951827
mydriasis,0.008796658403951827
bladder,0.008796658403951827
muscle,0.008796658403951827
icbd,0.008796658403951827
hypromellose,0.008796658403951827
hydrochloride,0.008796658403951827
recombinant,0.008796658403951827
court,0.008796658403951827
authorizing,0.008796658403951827
microcrystalline,0.008796658403951827
capable,0.008796658403951827
reactivation,0.008796658403951827
catheter,0.008796658403951827
cooperation,0.008796658403951827
parenteral,0.008796658403951827
pao2,0.008796658403951827
realization,0.008796658403951827
cava,0.008796658403951827
conjunction,0.008796658403951827
percutaneous,0.008796658403951827
patch,0.008796658403951827
herpetic,0.008796658403951827
5n,0.008796658403951827
pituitary,0.008796658403951827
physiologic,0.008796658403951827
cellulose,0.008796658403951827
completely,0.008796658403951827
pressures,0.008796658403951827
chloride,0.008796658403951827
chromosome,0.008796658403951827
precludes,0.008796658403951827
positivity,0.008796658403951827
colloidal,0.008796658403951827
chlorambucil,0.008796658403951827
undergone,0.008796658403951827
450,0.008796658403951827
ustekinumab,0.008796658403951827
uveitic,0.008796658403951827
uropathogen,0.008796658403951827
vena,0.008796658403951827
10mm,0.008796658403951827
washout,0.008796658403951827
16,0.007867617311420546
radiation,0.007867617311420546
place,0.007867617311420546
tocilizumab,0.007867617311420546
transfusions,0.007867617311420546
neurological,0.007867617311420546
appendix,0.007867617311420546
neutrophil,0.007867617311420546
cycles,0.007867617311420546
release,0.007867617311420546
biopsies,0.007867617311420546
calculated,0.007867617311420546
ratio,0.007867617311420546
11,0.007867617311420546
17,0.007867617311420546
2014,0.007867617311420546
inflammatory,0.007867617311420546
limited,0.007867617311420546
syndromes,0.007867617311420546
double,0.007867617311420546
m2,0.007867617311420546
inhibitor,0.007867617311420546
projected,0.0075907944461526865
verified,0.0075907944461526865
phosphate,0.0075907944461526865
prothrombin,0.0075907944461526865
clonal,0.0075907944461526865
365,0.0075907944461526865
cdeis,0.0075907944461526865
cap,0.0075907944461526865
components,0.0075907944461526865
coli,0.0075907944461526865
culture,0.0075907944461526865
sepsis,0.0075907944461526865
curative,0.0075907944461526865
deficiency,0.0075907944461526865
mrss,0.0075907944461526865
country,0.0075907944461526865
hospitalized,0.0075907944461526865
csf,0.0075907944461526865
cream,0.0075907944461526865
cytogenetic,0.0075907944461526865
bacterial,0.0075907944461526865
budesonide,0.0075907944461526865
partners,0.0075907944461526865
magnesium,0.0075907944461526865
sperm,0.0075907944461526865
sponge,0.0075907944461526865
anticipated,0.0075907944461526865
distinct,0.0075907944461526865
signing,0.0075907944461526865
small,0.0075907944461526865
monthly,0.0075907944461526865
sickle,0.0075907944461526865
shock,0.0075907944461526865
segmental,0.0075907944461526865
lineage,0.0075907944461526865
flu,0.0075907944461526865
suffering,0.0075907944461526865
donnees,0.0075907944461526865
subcutaneous,0.0075907944461526865
thoracic,0.0075907944461526865
encephalitis,0.0075907944461526865
edge,0.0075907944461526865
effusion,0.0075907944461526865
lethargy,0.0075907944461526865
laws,0.0075907944461526865
linked,0.0075907944461526865
field,0.0075907944461526865
igg,0.0075907944461526865
existing,0.0075907944461526865
fibrosis,0.0075907944461526865
undergo,0.0075907944461526865
withdrawn,0.0075907944461526865
globulin,0.0075907944461526865
72,0.0075907944461526865
vessels,0.0075907944461526865
haplo,0.0070280410446671125
conditioning,0.0070280410446671125
increase,0.0070280410446671125
doses,0.0070280410446671125
pre,0.0070280410446671125
value,0.0070280410446671125
capmatinib,0.0070280410446671125
greater,0.0070280410446671125
macular,0.0070280410446671125
unrelated,0.0070280410446671125
sensitivity,0.0070280410446671125
complications,0.0070280410446671125
rates,0.0070280410446671125
behcets,0.0070280410446671125
prescription,0.006655453694287762
immunosuppressants,0.006655453694287762
strong,0.006655453694287762
advanced,0.006655453694287762
block,0.006655453694287762
immunosuppression,0.006655453694287762
dosage,0.006655453694287762
lymphoma,0.006655453694287762
white,0.006655453694287762
immunization,0.006655453694287762
conditions,0.006655453694287762
hsv,0.006655453694287762
persistent,0.006655453694287762
american,0.006655453694287762
aminotransferase,0.006655453694287762
label,0.006655453694287762
lack,0.006655453694287762
proven,0.006655453694287762
sustained,0.006655453694287762
limit,0.006655453694287762
maintain,0.006655453694287762
controlled,0.006655453694287762
outside,0.006655453694287762
brochure,0.006655453694287762
400,0.006655453694287762
publique,0.006655453694287762
59,0.006655453694287762
agreed,0.006655453694287762
prednisolone,0.006655453694287762
forced,0.006655453694287762
records,0.006655453694287762
induction,0.006655453694287762
mild,0.006655453694287762
pediatric,0.006655453694287762
admission,0.006655453694287762
approved,0.006655453694287762
enrollment,0.006655453694287762
bacteria,0.006655453694287762
fvc,0.006655453694287762
ms,0.006655453694287762
plus,0.006655453694287762
thymocyte,0.006655453694287762
prevention,0.006655453694287762
whichever,0.006655453694287762
thrombocytopenia,0.006655453694287762
shall,0.006655453694287762
volume,0.006655453694287762
mmf,0.006655453694287762
acr,0.006655453694287762
molecular,0.006655453694287762
compliance,0.006655453694287762
conduct,0.006655453694287762
requirements,0.006655453694287762
invasive,0.006655453694287762
initiated,0.006655453694287762
marker,0.006655453694287762
discretion,0.006655453694287762
intravenously,0.006655453694287762
intolerance,0.006655453694287762
digestive,0.006655453694287762
despite,0.006655453694287762
chorioretinal,0.006655453694287762
nephropathy,0.006655453694287762
sign,0.006655453694287762
microalbuminuria,0.006655453694287762
judgment,0.005891224654243882
ph,0.005891224654243882
absolute,0.005891224654243882
fish,0.005891224654243882
infarct,0.005891224654243882
entry,0.005891224654243882
enrolment,0.005891224654243882
acuity,0.005891224654243882
modification,0.005891224654243882
mmol,0.005891224654243882
vital,0.005891224654243882
grafalon,0.005891224654243882
500,0.005891224654243882
hematological,0.005891224654243882
demonstrate,0.005891224654243882
300,0.005891224654243882
nei,0.005891224654243882
choice,0.005891224654243882
chosen,0.005891224654243882
objective,0.005891224654243882
identification,0.005891224654243882
underlying,0.005891224654243882
cov,0.005891224654243882
pathology,0.005891224654243882
hemolytic,0.005891224654243882
dna,0.005891224654243882
provided,0.005891224654243882
ebv,0.005891224654243882
continue,0.005891224654243882
abo,0.005891224654243882
ventilation,0.005891224654243882
identified,0.005891224654243882
fludarabine,0.005891224654243882
95,0.005891224654243882
potentially,0.005891224654243882
investigators,0.0052450782076136964
55,0.0052450782076136964
48,0.0052450782076136964
measure,0.0052450782076136964
opinion,0.0052450782076136964
refer,0.0052450782076136964
start,0.0052450782076136964
spartalizumab,0.0052450782076136964
manifestations,0.0052450782076136964
concomitant,0.0052450782076136964
inflammation,0.0052450782076136964
infusion,0.0052450782076136964
index,0.0052450782076136964
unit,0.0052450782076136964
presented,0.0052450782076136964
good,0.0052450782076136964
present,0.0052450782076136964
visual,0.0052450782076136964
classic,0.0052450782076136964
haze,0.0052450782076136964
sct,0.0052450782076136964
testing,0.0052450782076136964
withdrawal,0.0052450782076136964
edema,0.004685360696444742
arm,0.004685360696444742
increased,0.004685360696444742
groups,0.004685360696444742
poor,0.004685360696444742
gvhd,0.004685360696444742
daily,0.004685360696444742
chimerism,0.004685360696444742
refractory,0.004685360696444742
ocular,0.004685360696444742
met,0.004685360696444742
collection,0.004685360696444742
second,0.004685360696444742
best,0.004685360696444742
resolution,0.004685360696444742
vessel,0.004685360696444742
decision,0.004685360696444742
death,0.004685360696444742
evolution,0.004685360696444742
vitreous,0.004685360696444742
interval,0.004685360696444742
level,0.004685360696444742
benefit,0.004685360696444742
additional,0.004685360696444742
opportunistic,0.004398329201975914
h2,0.004398329201975914
opacities,0.004398329201975914
opacification,0.004398329201975914
nicolas,0.004398329201975914
h2o,0.004398329201975914
sampled,0.004398329201975914
norepinephrine,0.004398329201975914
nomegestrol,0.004398329201975914
nodules,0.004398329201975914
nsaids,0.004398329201975914
ctla4,0.004398329201975914
104,0.004398329201975914
xanthine,0.004398329201975914
17q,0.004398329201975914
restriction,0.004398329201975914
188,0.004398329201975914
researchers,0.004398329201975914
water,0.004398329201975914
wcbp,0.004398329201975914
representative,0.004398329201975914
representant,0.004398329201975914
crospovidone,0.004398329201975914
pac02,0.004398329201975914
ozurdex,0.004398329201975914
cr1,0.004398329201975914
covered,0.004398329201975914
couverture,0.004398329201975914
cousin,0.004398329201975914
couple,0.004398329201975914
guardian,0.004398329201975914
guideline,0.004398329201975914
cotrimoxazole,0.004398329201975914
nucleocapsid,0.004398329201975914
paco2,0.004398329201975914
sat02,0.004398329201975914
schizophrenia,0.004398329201975914
b19,0.004398329201975914
myeloblative,0.004398329201975914
cytomegalovirus,0.004398329201975914
cytologic,0.004398329201975914
cystic,0.004398329201975914
mutations,0.004398329201975914
murin,0.004398329201975914
multifocal,0.004398329201975914
vii,0.004398329201975914
bg9588,0.004398329201975914
artpo,0.004398329201975914
setons,0.004398329201975914
viii,0.004398329201975914
dated,0.004398329201975914
glycerol,0.004398329201975914
danlos,0.004398329201975914
serologic,0.004398329201975914
septal,0.004398329201975914
5q,0.004398329201975914
60mmhg,0.004398329201975914
7q,0.004398329201975914
creatininemia,0.004398329201975914
crisis,0.004398329201975914
s0,0.004398329201975914
rt,0.004398329201975914
vera,0.004398329201975914
roster,0.004398329201975914
ropinirole,0.004398329201975914
roactemra,0.004398329201975914
obstructive,0.004398329201975914
neuroimaging,0.004398329201975914
neurogenic,0.004398329201975914
nephrostomy,0.004398329201975914
25mmhg,0.004398329201975914
11q23,0.004398329201975914
neck,0.004398329201975914
000,0.004398329201975914
av,0.004398329201975914
beneficiary,0.004398329201975914
glycol,0.004398329201975914
behcet,0.004398329201975914
glycolate,0.004398329201975914
behaviour,0.004398329201975914
barnich,0.004398329201975914
goldmann,0.004398329201975914
neoplasms,0.004398329201975914
causative,0.004398329201975914
rectum,0.004398329201975914
caused,0.004398329201975914
cavity,0.004398329201975914
cd40l,0.004398329201975914
recist,0.004398329201975914
reaching,0.004398329201975914
pumonary,0.004398329201975914
pyuria,0.004398329201975914
breakage,0.004398329201975914
brca,0.004398329201975914
brain,0.004398329201975914
monobasic,0.004398329201975914
poloxamer,0.004398329201975914
peep,0.004398329201975914
polycythemia,0.004398329201975914
pathways,0.004398329201975914
polysorbate,0.004398329201975914
pathologies,0.004398329201975914
patches,0.004398329201975914
parvovirus,0.004398329201975914
persistant,0.004398329201975914
perinephric,0.004398329201975914
porphyria,0.004398329201975914
paroxysmal,0.004398329201975914
cocktail,0.004398329201975914
bradycardia,0.004398329201975914
concurrently,0.004398329201975914
college,0.004398329201975914
community,0.004398329201975914
phenylephrine,0.004398329201975914
complicated,0.004398329201975914
phenytoin,0.004398329201975914
pills,0.004398329201975914
plasmatic,0.004398329201975914
complex,0.004398329201975914
pneumocystis,0.004398329201975914
carriers,0.004398329201975914
carcinomas,0.004398329201975914
refers,0.004398329201975914
quinolones,0.004398329201975914
capsular,0.004398329201975914
rabbit,0.004398329201975914
caps,0.004398329201975914
ranieri,0.004398329201975914
pericardial,0.004398329201975914
conjugated,0.004398329201975914
confound,0.004398329201975914
confined,0.004398329201975914
conduction,0.004398329201975914
circi,0.004398329201975914
pt1,0.004398329201975914
catherization,0.004398329201975914
qualify,0.004398329201975914
formal,0.004398329201975914
pregelatinized,0.004398329201975914
premenopausal,0.004398329201975914
hrct,0.004398329201975914
glass,0.004398329201975914
cerebrospinal,0.004398329201975914
gilz,0.004398329201975914
generally,0.004398329201975914
gave,0.004398329201975914
hbc,0.004398329201975914
cf,0.004398329201975914
cfu,0.004398329201975914
parenterally,0.004398329201975914
vegf,0.004398329201975914
vault,0.004398329201975914
vasopressor,0.004398329201975914
3rd,0.004398329201975914
circumstance,0.004398329201975914
bipolar,0.004398329201975914
cirrhosis,0.004398329201975914
remained,0.004398329201975914
reliable,0.004398329201975914
reversible,0.004398329201975914
bile,0.004398329201975914
biggest,0.004398329201975914
worldwide,0.004398329201975914
vein,0.004398329201975914
parental,0.004398329201975914
prostatic,0.004398329201975914
protected,0.004398329201975914
continuously,0.004398329201975914
constitutional,0.004398329201975914
connective,0.004398329201975914
parasitic,0.004398329201975914
pap,0.004398329201975914
pao,0.004398329201975914
refrain,0.004398329201975914
calendar,0.004398329201975914
calcium,0.004398329201975914
preferable,0.004398329201975914
oxide,0.004398329201975914
costimulation,0.004398329201975914
psychiatrist,0.004398329201975914
correct,0.004398329201975914
contraceptionassociated,0.004398329201975914
psychosis,0.004398329201975914
bortezomib,0.004398329201975914
book,0.004398329201975914
bmi,0.004398329201975914
bmdw,0.004398329201975914
blockers,0.004398329201975914
pose,0.004398329201975914
predisposition,0.004398329201975914
brother,0.004398329201975914
judgement,0.004398329201975914
join,0.004398329201975914
epinephrine,0.004398329201975914
enterocystoplasty,0.004398329201975914
interpretation,0.004398329201975914
thrombopoietin,0.004398329201975914
thrombocythemia,0.004398329201975914
thiotepa,0.004398329201975914
theorical,0.004398329201975914
theophylline,0.004398329201975914
thalassemias,0.004398329201975914
esomeprazole,0.004398329201975914
erythropoietin,0.004398329201975914
acetate,0.004398329201975914
miami,0.004398329201975914
tki,0.004398329201975914
tizanidine,0.004398329201975914
administrative,0.004398329201975914
acyclovir,0.004398329201975914
inserm,0.004398329201975914
inr,0.004398329201975914
injectables,0.004398329201975914
infected,0.004398329201975914
infants,0.004398329201975914
5mm,0.004398329201975914
unresolved,0.004398329201975914
unresectable,0.004398329201975914
expose,0.004398329201975914
40ml,0.004398329201975914
4000,0.004398329201975914
tonometry,0.004398329201975914
ef,0.004398329201975914
edetate,0.004398329201975914
edentate,0.004398329201975914
killed,0.004398329201975914
algorithm,0.004398329201975914
albumin,0.004398329201975914
alanine,0.004398329201975914
ahsct,0.004398329201975914
suspicion,0.004398329201975914
supra,0.004398329201975914
suppressive,0.004398329201975914
ionizing,0.004398329201975914
involuntary,0.004398329201975914
endotype,0.004398329201975914
talc,0.004398329201975914
intolerant,0.004398329201975914
admitted,0.004398329201975914
t38c,0.004398329201975914
t2,0.004398329201975914
t1,0.004398329201975914
syphilis,0.004398329201975914
synechiae,0.004398329201975914
symptothermal,0.004398329201975914
tca,0.004398329201975914
endoscope,0.004398329201975914
endocarditis,0.004398329201975914
endocan,0.004398329201975914
encephalopathy,0.004398329201975914
empirically,0.004398329201975914
embolism,0.004398329201975914
inv,0.004398329201975914
agonists,0.004398329201975914
expired,0.004398329201975914
expertise,0.004398329201975914
expectancy,0.004398329201975914
im,0.004398329201975914
universite,0.004398329201975914
universelle,0.004398329201975914
unfit,0.004398329201975914
umr,0.004398329201975914
tutelle,0.004398329201975914
idec,0.004398329201975914
urologic,0.004398329201975914
ureteral,0.004398329201975914
unsuitable,0.004398329201975914
unstable,0.004398329201975914
verbal,0.004398329201975914
ideation,0.004398329201975914
clairance,0.004398329201975914
375,0.004398329201975914
3000,0.004398329201975914
2nd,0.004398329201975914
probenecid,0.004398329201975914
prisoners,0.004398329201975914
priority,0.004398329201975914
12p,0.004398329201975914
prohibit,0.004398329201975914
propylene,0.004398329201975914
88,0.004398329201975914
whevener,0.004398329201975914
vulnerable,0.004398329201975914
vi,0.004398329201975914
1x109,0.004398329201975914
checking,0.004398329201975914
hypoxia,0.004398329201975914
fio2,0.004398329201975914
fibrillation,0.004398329201975914
ineligible,0.004398329201975914
insult,0.004398329201975914
etonogestrel,0.004398329201975914
etdrs,0.004398329201975914
estrogenic,0.004398329201975914
excepted,0.004398329201975914
excellent,0.004398329201975914
examples,0.004398329201975914
indwelling,0.004398329201975914
tumoral,0.004398329201975914
abetimus,0.004398329201975914
98,0.004398329201975914
exception,0.004398329201975914
96h,0.004398329201975914
8g,0.004398329201975914
tuberculin,0.004398329201975914
turners,0.004398329201975914
incomplete,0.004398329201975914
incarcerated,0.004398329201975914
incapacity,0.004398329201975914
inability,0.004398329201975914
impossible,0.004398329201975914
implant,0.004398329201975914
impeding,0.004398329201975914
imp,0.004398329201975914
immunosuppressed,0.004398329201975914
excipient,0.004398329201975914
exchanges,0.004398329201975914
97,0.004398329201975914
mianserine,0.004398329201975914
131,0.004398329201975914
methylprednisolone,0.004398329201975914
meter,0.004398329201975914
metastases,0.004398329201975914
mesenteric,0.004398329201975914
mental,0.004398329201975914
meningoencephalitis,0.004398329201975914
mirtazapine,0.004398329201975914
designees,0.004398329201975914
directed,0.004398329201975914
dipropionate,0.004398329201975914
diffusion,0.004398329201975914
dibasic,0.004398329201975914
ehlers,0.004398329201975914
mdw,0.004398329201975914
society,0.004398329201975914
smp,0.004398329201975914
smd,0.004398329201975914
sister,0.004398329201975914
singer,0.004398329201975914
simultaneous,0.004398329201975914
macrogol,0.004398329201975914
diverticulitis,0.004398329201975914
disturbances,0.004398329201975914
distress,0.004398329201975914
distearate,0.004398329201975914
dissection,0.004398329201975914
aphtosis,0.004398329201975914
aortic,0.004398329201975914
dexamethasone,0.004398329201975914
molecule,0.004398329201975914
mole,0.004398329201975914
mobilization,0.004398329201975914
atherosclerosis,0.004398329201975914
50g,0.004398329201975914
4n,0.004398329201975914
470,0.004398329201975914
264,0.004398329201975914
vasopressin,0.004398329201975914
fistulas,0.004398329201975914
fistula,0.004398329201975914
historically,0.004398329201975914
histidine,0.004398329201975914
fungals,0.004398329201975914
fumarate,0.004398329201975914
microangiopathic,0.004398329201975914
fralle,0.004398329201975914
atelectasis,0.004398329201975914
assignee,0.004398329201975914
asplenia,0.004398329201975914
aspartate,0.004398329201975914
ascent,0.004398329201975914
depleting,0.004398329201975914
dependance,0.004398329201975914
arginine,0.004398329201975914
ards,0.004398329201975914
appear,0.004398329201975914
d1,0.004398329201975914
cytoreductive,0.004398329201975914
monogamous,0.004398329201975914
microsined,0.004398329201975914
fraumeni,0.004398329201975914
homeless,0.004398329201975914
flutter,0.004398329201975914
fluoropyrimidine,0.004398329201975914
vasectomized,0.004398329201975914
valves,0.004398329201975914
50mmhg,0.004398329201975914
steroidal,0.004398329201975914
sterility,0.004398329201975914
stents,0.004398329201975914
stearyl,0.004398329201975914
stearate,0.004398329201975914
sucrose,0.004398329201975914
draining,0.004398329201975914
linguistic,0.004398329201975914
limb,0.004398329201975914
antivirals,0.004398329201975914
levonorgestrel,0.004398329201975914
leukoencephalopathy,0.004398329201975914
leucocytes,0.004398329201975914
locally,0.004398329201975914
liters,0.004398329201975914
leucocyte,0.004398329201975914
leflunomide,0.004398329201975914
lbs,0.004398329201975914
latex,0.004398329201975914
language,0.004398329201975914
lactating,0.004398329201975914
suppress,0.004398329201975914
suppository,0.004398329201975914
aminoside,0.004398329201975914
amendment,0.004398329201975914
li,0.004398329201975914
antimalarial,0.004398329201975914
antiherpetic,0.004398329201975914
anaemia,0.004398329201975914
srs2,0.004398329201975914
spo2,0.004398329201975914
spermicidal,0.004398329201975914
marfan,0.004398329201975914
mapping,0.004398329201975914
mannitol,0.004398329201975914
maladie,0.004398329201975914
maize,0.004398329201975914
madrs,0.004398329201975914
dopamine,0.004398329201975914
donating,0.004398329201975914
donate,0.004398329201975914
ifn,0.004398329201975914
anosmia,0.004398329201975914
aneurysms,0.004398329201975914
aneurysm,0.004398329201975914
anal,0.004398329201975914
easy,0.004398329201975914
e172,0.004398329201975914
e171,0.004398329201975914
dysgueusia,0.004398329201975914
dusp,0.004398329201975914
duct,0.004398329201975914
dual,0.004398329201975914
subtenons,0.004398329201975914
favourable,0.004398329201975914
fanconi,0.004398329201975914
express,0.004398329201975914
antibacterials,0.004398329201975914
20mg,0.0037953972230763433
2000,0.0037953972230763433
website,0.0037953972230763433
200,0.0037953972230763433
38c,0.0037953972230763433
30g,0.0037953972230763433
fulfilled,0.0037953972230763433
fr,0.0037953972230763433
household,0.0037953972230763433
fluorescein,0.0037953972230763433
fluids,0.0037953972230763433
vasoconstrictor,0.0037953972230763433
categories,0.0037953972230763433
cataract,0.0037953972230763433
ptt,0.0037953972230763433
premedication,0.0037953972230763433
precluding,0.0037953972230763433
proteasome,0.0037953972230763433
properties,0.0037953972230763433
properly,0.0037953972230763433
program,0.0037953972230763433
pleural,0.0037953972230763433
combining,0.0037953972230763433
combine,0.0037953972230763433
film,0.0037953972230763433
fields,0.0037953972230763433
fev1,0.0037953972230763433
febrile,0.0037953972230763433
fatigue,0.0037953972230763433
familial,0.0037953972230763433
extreme,0.0037953972230763433
expressed,0.0037953972230763433
uti,0.0037953972230763433
7mg,0.0037953972230763433
immediately,0.0037953972230763433
ileocolonoscopy,0.0037953972230763433
unconsciousness,0.0037953972230763433
ulceration,0.0037953972230763433
ulcerated,0.0037953972230763433
receptor,0.0037953972230763433
phenotype,0.0037953972230763433
complication,0.0037953972230763433
carbon,0.0037953972230763433
cancers,0.0037953972230763433
tyrosine,0.0037953972230763433
typing,0.0037953972230763433
inactivity,0.0037953972230763433
inefficacy,0.0037953972230763433
excessive,0.0037953972230763433
example,0.0037953972230763433
trv,0.0037953972230763433
troponin,0.0037953972230763433
treating,0.0037953972230763433
inferior,0.0037953972230763433
eular,0.0037953972230763433
eu,0.0037953972230763433
pcra,0.0037953972230763433
participating,0.0037953972230763433
participated,0.0037953972230763433
periodic,0.0037953972230763433
performans,0.0037953972230763433
confirmation,0.0037953972230763433
bowel,0.0037953972230763433
institute,0.0037953972230763433
inspired,0.0037953972230763433
transverse,0.0037953972230763433
transformed,0.0037953972230763433
accepted,0.0037953972230763433
ac,0.0037953972230763433
transcriptomic,0.0037953972230763433
tp,0.0037953972230763433
administrated,0.0037953972230763433
adjustment,0.0037953972230763433
regional,0.0037953972230763433
contained,0.0037953972230763433
considers,0.0037953972230763433
pancreatitis,0.0037953972230763433
pains,0.0037953972230763433
regardless,0.0037953972230763433
refusal,0.0037953972230763433
caecum,0.0037953972230763433
brutal,0.0037953972230763433
adhesive,0.0037953972230763433
adequately,0.0037953972230763433
episodes,0.0037953972230763433
epi,0.0037953972230763433
enterobacteriaceae,0.0037953972230763433
enrol,0.0037953972230763433
intercurrent,0.0037953972230763433
resection,0.0037953972230763433
replication,0.0037953972230763433
repair,0.0037953972230763433
blocks,0.0037953972230763433
ending,0.0037953972230763433
intraocular,0.0037953972230763433
interview,0.0037953972230763433
keratitis,0.0037953972230763433
kaposis,0.0037953972230763433
joints,0.0037953972230763433
isoniazid,0.0037953972230763433
enhancement,0.0037953972230763433
oncolytic,0.0037953972230763433
oesogastric,0.0037953972230763433
oedema,0.0037953972230763433
occlusive,0.0037953972230763433
betamethasone,0.0037953972230763433
reticulocytes,0.0037953972230763433
tachycardia,0.0037953972230763433
swab,0.0037953972230763433
electrophoresis,0.0037953972230763433
kinase,0.0037953972230763433
sustaining,0.0037953972230763433
alemtuzumab,0.0037953972230763433
susceptible,0.0037953972230763433
league,0.0037953972230763433
latest,0.0037953972230763433
lactate,0.0037953972230763433
l2,0.0037953972230763433
ambulatory,0.0037953972230763433
alternatively,0.0037953972230763433
rifampicin,0.0037953972230763433
rheumatology,0.0037953972230763433
rheumatism,0.0037953972230763433
optional,0.0037953972230763433
allogenic,0.0037953972230763433
dysfunction,0.0037953972230763433
stratum,0.0037953972230763433
started,0.0037953972230763433
mab,0.0037953972230763433
lvef,0.0037953972230763433
lowest,0.0037953972230763433
angio,0.0037953972230763433
ss,0.0037953972230763433
normalized,0.0037953972230763433
crt,0.0037953972230763433
crossed,0.0037953972230763433
saliva,0.0037953972230763433
routine,0.0037953972230763433
risks,0.0037953972230763433
maintained,0.0037953972230763433
mdrd,0.0037953972230763433
distance,0.0037953972230763433
discussed,0.0037953972230763433
specifically,0.0037953972230763433
antinuclear,0.0037953972230763433
anticoagulants,0.0037953972230763433
species,0.0037953972230763433
spc,0.0037953972230763433
sp02,0.0037953972230763433
meetings,0.0037953972230763433
sonography,0.0037953972230763433
sole,0.0037953972230763433
avoiding,0.0037953972230763433
n1,0.0037953972230763433
myelitis,0.0037953972230763433
neuro,0.0037953972230763433
nerve,0.0037953972230763433
neoplasia,0.0037953972230763433
nelarabine,0.0037953972230763433
sirolimus,0.0037953972230763433
simple,0.0037953972230763433
minimize,0.0037953972230763433
desire,0.0037953972230763433
derivatives,0.0037953972230763433
depressive,0.0037953972230763433
aseptic,0.0037953972230763433
serologies,0.0037953972230763433
multidisciplinary,0.0037953972230763433
mucosa,0.0037953972230763433
deep,0.0037953972230763433
selective,0.0037953972230763433
segments,0.0037953972230763433
significantly,0.0037953972230763433
apply,0.0037953972230763433
apparition,0.0037953972230763433
apparent,0.0037953972230763433
shows,0.0037953972230763433
monoxide,0.0037953972230763433
showing,0.0037953972230763433
short,0.0037953972230763433
sharing,0.0037953972230763433
asthma,0.0037953972230763433
vh,0.0037953972230763433
haemoglobin,0.0037953972230763433
haematological,0.0037953972230763433
guidelines,0.0037953972230763433
hematologic,0.0037953972230763433
healthcare,0.0037953972230763433
hcsp,0.0037953972230763433
glucocorticoid,0.0037953972230763433
glaucoma,0.0037953972230763433
gel,0.0037953972230763433
gadolinium,0.0037953972230763433
cm,0.0037953972230763433
classified,0.0037953972230763433
classical,0.0037953972230763433
ckd,0.0037953972230763433
cessation,0.0037953972230763433
02,0.0037953972230763433
plasmapheresis,0.003327726847143881
physical,0.003327726847143881
phosphatase,0.003327726847143881
colonized,0.003327726847143881
cd4,0.003327726847143881
cd20,0.003327726847143881
5l,0.003327726847143881
des,0.003327726847143881
dependency,0.003327726847143881
mrd,0.003327726847143881
serological,0.003327726847143881
arthritis,0.003327726847143881
area,0.003327726847143881
sight,0.003327726847143881
monitored,0.003327726847143881
hydrocortisone,0.003327726847143881
features,0.003327726847143881
extensive,0.003327726847143881
experienced,0.003327726847143881
myocarditis,0.003327726847143881
murine,0.003327726847143881
nasal,0.003327726847143881
avoid,0.003327726847143881
degree,0.003327726847143881
microns,0.003327726847143881
cases,0.003327726847143881
pharmacodynamics,0.003327726847143881
persons,0.003327726847143881
radiological,0.003327726847143881
independently,0.003327726847143881
tubes,0.003327726847143881
abnormality,0.003327726847143881
ab,0.003327726847143881
european,0.003327726847143881
established,0.003327726847143881
essential,0.003327726847143881
match,0.003327726847143881
mass,0.003327726847143881
apn,0.003327726847143881
antidepressant,0.003327726847143881
special,0.003327726847143881
medullar,0.003327726847143881
medium,0.003327726847143881
direct,0.003327726847143881
determination,0.003327726847143881
software,0.003327726847143881
scheduled,0.003327726847143881
conjugate,0.003327726847143881
recovery,0.003327726847143881
transmission,0.003327726847143881
birads,0.003327726847143881
relationship,0.003327726847143881
mammography,0.003327726847143881
make,0.003327726847143881
creatininuria,0.003327726847143881
room,0.003327726847143881
rodnan,0.003327726847143881
magnetic,0.003327726847143881
registry,0.003327726847143881
contact,0.003327726847143881
adenocarcinoma,0.003327726847143881
intervention,0.003327726847143881
ensuring,0.003327726847143881
enroll,0.003327726847143881
threshold,0.003327726847143881
longer,0.003327726847143881
load,0.003327726847143881
earlier,0.003327726847143881
stratified,0.003327726847143881
stated,0.003327726847143881
replaced,0.003327726847143881
pain,0.003327726847143881
outpatient,0.003327726847143881
tested,0.003327726847143881
targeting,0.003327726847143881
eltrombopag,0.003327726847143881
joint,0.003327726847143881
biology,0.003327726847143881
responding,0.003327726847143881
resonance,0.003327726847143881
targeted,0.003327726847143881
l1,0.003327726847143881
ktr,0.003327726847143881
rheumatoid,0.003327726847143881
observational,0.003327726847143881
osteonecrosis,0.003327726847143881
option,0.003327726847143881
drop,0.003327726847143881
lines,0.003327726847143881
keytruda,0.003327726847143881
allocated,0.003327726847143881
alkaline,0.003327726847143881
air,0.003327726847143881
surgical,0.003327726847143881
superior,0.003327726847143881
alloimmunization,0.003327726847143881
rifaximin,0.003327726847143881
hr,0.003327726847143881
fluid,0.003327726847143881
fludrocortisone,0.003327726847143881
pt,0.003327726847143881
graaph,0.003327726847143881
glucocorticoids,0.003327726847143881
vasopressors,0.003327726847143881
checkpoint,0.003327726847143881
ciprofloxacin,0.003327726847143881
www,0.002945612327121941
01,0.002945612327121941
cerebral,0.002945612327121941
charge,0.002945612327121941
class,0.002945612327121941
gr,0.002945612327121941
106,0.002945612327121941
practice,0.002945612327121941
virological,0.002945612327121941
cr,0.002945612327121941
allograft,0.002945612327121941
kidney,0.002945612327121941
optical,0.002945612327121941
elderly,0.002945612327121941
like,0.002945612327121941
law,0.002945612327121941
crp,0.002945612327121941
particular,0.002945612327121941
participant,0.002945612327121941
mechanical,0.002945612327121941
sledai,0.002945612327121941
achieved,0.002945612327121941
toxicities,0.002945612327121941
tomography,0.002945612327121941
bcva,0.002945612327121941
medicine,0.002945612327121941
conventional,0.002945612327121941
lower,0.002945612327121941
analysed,0.002945612327121941
stroke,0.002945612327121941
require,0.002945612327121941
stay,0.002945612327121941
lupus,0.002945612327121941
overlap,0.002945612327121941
biomedical,0.002945612327121941
better,0.002945612327121941
biomarkers,0.002945612327121941
beta,0.002945612327121941
responsible,0.002945612327121941
responders,0.002945612327121941
respond,0.002945612327121941
possible,0.002945612327121941
common,0.002945612327121941
define,0.002945612327121941
mud,0.002945612327121941
coherence,0.002945612327121941
selena,0.002945612327121941
damage,0.002945612327121941
http,0.002945612327121941
proposed,0.002945612327121941
platelets,0.002945612327121941
180,0.002945612327121941
phenotypic,0.002945612327121941
attributed,0.002945612327121941
authority,0.002945612327121941
silent,0.002945612327121941
cycle,0.002945612327121941
candidate,0.002945612327121941
person,0.002945612327121941
complementary,0.002945612327121941
computed,0.002945612327121941
deterioration,0.002945612327121941
rapidly,0.002945612327121941
mismatch,0.002945612327121941
mesylate,0.002945612327121941
aa,0.002945612327121941
criterion,0.002945612327121941
niu,0.002945612327121941
ctcae,0.002945612327121941
sarcoma,0.002945612327121941
maximum,0.002945612327121941
addition,0.002945612327121941
thymoglobulin,0.002945612327121941
immediate,0.002945612327121941
expected,0.002945612327121941
80mg,0.002945612327121941
65,0.002945612327121941
eyes,0.002945612327121941
estimated,0.002945612327121941
especially,0.002945612327121941
diseases,0.002945612327121941
rapid,0.002945612327121941
induced,0.002945612327121941
twice,0.002945612327121941
improvement,0.002945612327121941
pembrolizumab,0.0026225391038068482
delayed,0.0026225391038068482
family,0.0026225391038068482
score,0.0026225391038068482
cause,0.0026225391038068482
follows,0.0026225391038068482
higher,0.0026225391038068482
flow,0.0026225391038068482
pr,0.0026225391038068482
support,0.0026225391038068482
chamber,0.0026225391038068482
review,0.0026225391038068482
centre,0.0026225391038068482
evaluation,0.0026225391038068482
2012,0.0026225391038068482
effects,0.0026225391038068482
onset,0.0026225391038068482
late,0.0026225391038068482
line,0.0026225391038068482
2013,0.0026225391038068482
plan,0.0026225391038068482
2016,0.0026225391038068482
decrease,0.0026225391038068482
points,0.0026225391038068482
exposure,0.0026225391038068482
exposed,0.0026225391038068482
https,0.0026225391038068482
sites,0.0026225391038068482
factor,0.0026225391038068482
neutrophils,0.0026225391038068482
infusions,0.0026225391038068482
parameters,0.0026225391038068482
interaction,0.0026225391038068482
reference,0.0026225391038068482
medications,0.0026225391038068482
perform,0.0026225391038068482
residual,0.0026225391038068482
low,0.0026225391038068482
overload,0.0026225391038068482
therapeutic,0.0026225391038068482
iron,0.0026225391038068482
kaposi,0.0026225391038068482
endpoints,0.0026225391038068482
report,0.0026225391038068482
loss,0.0026225391038068482
starting,0.0026225391038068482
percentage,0.0026225391038068482
camostat,0.0026225391038068482
mds,0.0026225391038068482
reduce,0.0026225391038068482
partial,0.0026225391038068482
taken,0.0026225391038068482
mixed,0.0026225391038068482
et,0.0026225391038068482
observed,0.002342680348222371
order,0.002342680348222371
followed,0.002342680348222371
prca,0.002342680348222371
france,0.002342680348222371
amplification,0.002342680348222371
modified,0.002342680348222371
probability,0.002342680348222371
ongoing,0.002342680348222371
survival,0.002342680348222371
overall,0.002342680348222371
outcome,0.002342680348222371
remission,0.002342680348222371
early,0.002342680348222371
tnf,0.002342680348222371
toxicity,0.002342680348222371
main,0.002342680348222371
samples,0.002342680348222371
adapted,0.002342680348222371
analysis,0.002342680348222371
step,0.002342680348222371
information,0.002342680348222371
phase,0.002342680348222371
infections,0.002342680348222371
event,0.002342680348222371
includes,0.002342680348222371
immune,0.002342680348222371
date,0.002342680348222371
plasma,0.002342680348222371
24,0.002342680348222371
